Global Argatroban Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Argatroban Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 6535.
Argatroban report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Argatroban market is projected to reach US$ 42 million in 2034, increasing from US$ 63 million in 2022, with the CAGR of -5.6% during the period of 2024 to 2034. Demand from Heparin-induced Thrombocytopenia (HIT) and Percutaneous Coronary Intervention are the major drivers for the industry.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Argatroban market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Argatroban market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Argatroban, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Argatroban industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Argatroban in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Argatroban introduction, etc. Argatroban Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Argatroban market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Argatroban report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Argatroban market is projected to reach US$ 42 million in 2034, increasing from US$ 63 million in 2022, with the CAGR of -5.6% during the period of 2024 to 2034. Demand from Heparin-induced Thrombocytopenia (HIT) and Percutaneous Coronary Intervention are the major drivers for the industry.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Argatroban market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Argatroban market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Argatroban, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Argatroban industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Argatroban in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Argatroban introduction, etc. Argatroban Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Argatroban market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices